The Effect of Dexlansoprazole MR on Nocturnal Heartburn and GERD-Related Sleep Disturbances in Patients With Symptomatic GERD

The development and validation of a Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults

(2010) B. M. Spiegel et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

(2009) D. A. PEURA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor - evidence for dosing flexibility

(2009) R. D. LEE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease

(2009) R. FASS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of Gastroesophageal Reflux Disease on Sleep and Outcomes

(2009) Reema Mody et al.   Clinical Gastroenterology and Hepatology

Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials

(2009) Majid Vakily et al.   CURRENT MEDICAL RESEARCH AND OPINION

Treatment patterns and symptom control in patients with GERD: US community-based survey

(2009) William D. Chey et al.   CURRENT MEDICAL RESEARCH AND OPINION

The Relationship Between the Prevalence of Nighttime Gastroesophageal Reflux Disease and Disease Severity

(2009) Bonnie B. Dean et al.   DIGESTIVE DISEASES AND SCIENCES

Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study

(2008) M. NOCON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS